Go to contents
Go to menu
°Ë»ö¾î ÀÔ·Â
Ȩ
·Î±×ÀÎ
Áñ°Üã±âÃß°¡
ENGLlSH
°í±Þ°Ë»ö
Àú³Îº°°Ë»ö
¿ø¹®Á¦°ø Àú³Îº°°Ë»ö
¿¬±¸ºÐ¾ßº° °Ë»ö
ÇÐȸ/Çùȸ Á¤º¸
Àú³Î Á¤º¸
Àú³Î Åõ°í ±ÔÁ¤
KMbase ¼Ò°³
°øÁö»çÇ×
¾÷µ¥ÀÌÆ® Á¤º¸
³» Á¤º¸
ÀúÀå ³í¹®
°ü½ÉºÐ¾ß ³í¹®
°ü½ÉÇÐȸ/ÇмúÁ¤º¸
¿ø¹®½Åû
°ü½ÉºÐ¾ß °ü¸®
½ºÅ©¸³Æ® ȯ°æ¿¡¼ Áö¿øµË´Ï´Ù.
³í¹®°Ë»ö
°í±Þ°Ë»ö
Àú³Îº°°Ë»ö
¿ø¹®Á¦°ø Àú³Î°Ë»ö
¿¬±¸ºÐ¾ßº° °Ë»ö
SITE LINK
PubMed
Google Scholar
KoreaScience
NDSL
KoreaMed
RISS
MEDLIS
Cross Check
´ëÇѺñ´¢±â°úÇÐȸÁö
( Korean Journal of Urology )
: °Ë»ö°á°ú :
46
  
°Ë»ö°á°ú¸ðµÎ¼±ÅÃ
1
½Å¿ì¼ºÇü¼ú¿¡ ´ëÇÑ ¿ä·ÎÀüȯÀÇ È¿°ú
Pyeloplasty for Ureteropelvic Junction Obstruction: To Divert or Not to Divert
À̱æÈ£
¹Úµµ¿µ, Á¶ÅÂÇü
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 867 ~ 872
2
Àü¸³¼±¿äµµ³» º¸Çü¹°ÀÇ Àå±â À¯Ä¡¿¡ µû¸¥ ÇÕº´Áõ
Evaluation of Complications in Long-term Prostatic Stent Indwelling
ÀÌÁÖÈÆ
À̱¤¼ö
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 860 ~ 866
3
Áõ»óÀ» µ¿¹ÝÇÑ Àü¸³¼±ºñ´ëÁõ¿¡ ´ëÇÑ ÀÏÂ÷Àû Ä¡·á·Î¼ PrazosinÀÇ È¿°ú
The Effect of Prazosin as a First-Line Therapy for the Symptomatic Benign Prostatic Hypertrophy
ÀÌÁ¾Áø
ÃÖ¿ë¼·
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 855 ~ 859
4
³»ºÐºñ¿ä¼Ò¿Í ¿¬·ÉÀÌ ¾ç¼ºÀü¸³¼±ºñ´ëÁõ¿¡ ¹ÌÄ¡´Â ¿µÇâ
The Influence of Age and Endocrine Factors on the Volume of Benign Postatic Hyperplasia
¹ÚÁ¾ÈÆ
ÑÑܼÖÛ
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 850 ~ 854
5
ºñ´¢±â°èÀÇ È¾¹®±ÙÀ°Á¾ÀÇ ÀÓ»óÀû °íÂû
A Clinical Analysis of Rhabdomyosarcoma in the Genitourinar Tract
À̱æÈ£
ÃÖ°æ¿ì
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 842 ~ 849
6
ħÀ±¼º ¹æ±¤ÀÌÇà»óÇǼ¼Æ÷¾ÏÀÇ Cisplatin ¹× ¹æ»ç¼± º´¿ë¿ä¹ýÀÇ Ãʱâ°æÇè
Combined Cisplatin and Radiotherapy for Patients wih Invasive Bladder Carcinoma: A Preliminary Repor
...
ÃÖȣö
¹ÚöÈñ/±èõÀÏ/À̼ºÁØ/±èÁøÈñ/±è¿Á¹è
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 835 ~ 841
7
Àü¸³¼± Áúȯ¿¡ ÀÖ¾î¼ Enzyme¹æ¹ý (Tandem-E)À» ÀÌ¿ëÇÑ Àü¸³¼± ƯÀÌÇ׿ø(PSA)ÀÇ ÀÓ»óÀû ÀÇÀÇ
The Clinical Usefulness of SErum Prostate Specific Antigen(Tandem-E) in the Prostate Disease
ÀÌÁöÇ÷
±¸Á¤¿Ï
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 828 ~ 834
8
Àü¸³¼±ºñ´ëÁõ ȯÀÚ¿¡ ÀÖ¾î¼ Ç÷û PSAÄ¡¿Í °æÁ÷Àå ÃÊÀ½ÆÄ°Ë»ç¿ÍÀÇ »ó°ü°ü°è ¹× ÀÓ»óÀû ÀÇÀÇ
The Correlation of Serum Prostate Specific Antigen(PSA) and Prostatic Volume Measued by Transrectal
...
ÇÏ´ÞºÀ
ÀÌ»ó¼º/¹ÚöÈñ/À̼ºÁØ/À̼º¹®/¿ì¼º±¸
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 821 ~ 827
9
¸¸¼º ½ÅºÎÀü ȯÀÚ¿¡¼ ¹æ±¤ÀÇ º´¸®Á¶Á÷ÇÐÀû ¼Ò°ß
Histopathologic Findings of Bladder in Chronic Renal Failure
¿©¼ö°©
±èÇϽÄ, ±èÈ«±â
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 815 ~ 820
10
Ç÷Á¤¾×Áß È¯ÀÚ¿¡°Ô °æÁ÷Àå ÃÊÀ½ÆÄÃÔ¿µ¼úÀÇ ¼Ò°ß¿¡ ÀÇÇÑ ¿øÀÎ °íÂû
The Finding of Transrectal Ultrasonography in Evaluation of Organic Hemospermia
±èÀçÀÏ
¹Ú¼®»ê
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 811 ~ 814
11
½Å¼¼Æ÷¾ÏÀÇ º´±â °áÁ¤¿¡ ÀÖ¾î ¿µ»óÁø´Ü¹ýÀÇ ºñ±³ Æò°¡
A Study on the Comparision of Various Imaging Methods for the Saging of Renal cell Carcinoma
¹ÚÁØȯ
ÇѺ¸Çö
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 805 ~ 810
12
ÈòÁã¿¡¼ Ä®½·Åë·ÎÂ÷´ÜÁ¦°¡ À½°æ¹ß±â¿¡ ¹ÌÄ¡´Â È¿°ú
Effect of Calcium Channel Blockers on Penile Erection in Rats
Á¶Ã¶±Ô
¼ÁرÔ, ¹Úµ¿Ãá
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 796 ~ 804
13
Apomorphine-À¯¹ß À½°æ ¹ß±âÀÇ ¸»ÃʽŰæ Àü´Þ Åë·Î: ¹é¼¸ðµ¨¿¡¼ ½Å°æÀü±âÀÚ±Ø-À¯¹ß¹ß±â¿ÍÀÇ ºñ±³¸¦ ÅëÇÑ
...
The Infraspinal Neural Pathway of Apomorphine-induced Erection: an Experimental Study by the Compari
...
À̼º¿ø
¹éÀç½Â/¹Ú°üÇö/¿À½ÂÁØ/ÁÖ¸í¼ö/Á¶Çü±â
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 790 ~ 795
14
Áã¿¡¼ ȸÀåÀ» ÀÌ¿ëÇÑ ¹æ±¤È®Àå¼ú½Ã OctreotideÀÇ Á¡¾×ºÐºñ °¨¼ÒÈ¿°ú
The Effect of Ocreotide, a Long-acting Somatostatin Analogue, on the reduction of Mucosal SEcreation
...
À̱¤µ·
¾çÀÏÈ£
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 784 ~ 789
15
ÇãÇ÷¿¡ ÀÇÇÑ °íȯ¼Õ»ó½Ã Àú¿Â¿ä¹ý°ú ȸº¹½Ã °í¿Â¿ä¹ýÀÇ È¿°ú¿¡ ´ëÇÑ ½ÇÇèÀû ¿¬±¸
A Study on the Efffects of Hypothermia in the Initial Phase and Hyperthermia in the Recovery Phase o
...
ÀÚ¾ïÈç
ÀÌÁÖÀº
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 778 ~ 783
16
TGF- 1ÀÌ Àü¸³¼± ¼¼Æ÷Áõ½Ä¿¡ ¹ÌÄ¡´Â ¿µÇâ
Effect of Transforming Growth Factor 1 ib Orikuferatuib if Proliferation of Prostatic Cells
±èÇöÁÖ
·ù±Ù°©, ¾ÈÇÑÁ¾
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 770 ~ 777
17
Àü¸³¼±¾Ï¿¡¼ C-erbB-2 Á¾¾ç´Ü¹éÀÇ ¹ßÇö¿¡ °üÇÑ ¸é¿ªÁ¶Á÷ÈÇÐÀû ¿¬±¸
An Immunohistochemical Demonstration of C-erbB-2 Oncoprotein Expression in Prostatic Adenocarcinoma
ÃÖÁ¾º¸
õ ÁØ/±èÇÑ°â/±èÁ¦Á¾/°í¼º°Ç
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 764 ~ 769
18
SuraminÀÌ À½°æ ÆíÆò»óÇÇ¾Ï ¼¼Æ÷ÁÖ(CUPE-1)¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ½ÇÇèÀû ¿¬±¸
Experimental Study on the Effect of Suramin on Penile Squamous Carcinoma Cell Line(CUPE-1)
°ÀϱÔ
¿À¹®¸ñ
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 748 ~ 763
19
¹æ±¤ÀÌÇà»óÇǼ¼Æ÷¾Ï¿¡¼ Nucleolar Organizer Regions¸¦ ÀÌ¿ëÇÑ ¼¼Æ÷Áõ½Ä´É Æò°¡¿¡ °üÇÑ ¿¬±¸
Clinical Significance of Silver Binding Nucleolar Organizer Regions(AgNORs) in Transitional Cell Car
...
¹ÚÈ«¼®
õ ÁØ/ÇÑÁ¤È£/±èÇÑ°â/±èÁ¦Á¾/°í¼º°Ç
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 741 ~ 747
20
ChlorpromazineÀ¸·Î À¯¹ßµÈ À½°æÁö¼Ó ¹ß±âÁõ 1·Ê
A Case of Chlorpromazine Induced Priapism
°¹®È£
¼®ºÀö, ¾ç½ÂÇÐ
´ëÇѺñ´¢±â°úÇÐȸÁö
1993³â 34±Ç 4È£ 737 ~ 740
1
2
3